Fig. 3From: Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignanciesTherapeutic agents against MDSCs classified by mechanism in hematological malignancy. The main approaches to target MDSCs include [1] depleting MDSCs; [2] blocking MDSC recruitment to the tumor microenvironment (TME); [3] promoting the differentiation of MDSCs into mature myeloid cells; [4] blocking MDSC-mediated immunosuppressionBack to article page